Related content

Effect of CYP3A and ABCB1 Single Nucleotide Polymorphisms on the Pharmacokinetics and Pharmacodynamics of Calcineurin Inhibitors: Part I

By Staatz Christine E.   Goodman Lucy K.   Tett Susan E.  

Clinical Pharmacokinetics, Vol. 49, Iss. 3, 2010-03 ,pp. : 141-175

Adis International

Access to resources Recommend Favorite

Effect of CYP3A and ABCB1 Single Nucleotide Polymorphisms on the Pharmacokinetics and Pharmacodynamics of Calcineurin Inhibitors: Part II

By Staatz Christine E.   Goodman Lucy K.   Tett Susan E.  

Clinical Pharmacokinetics, Vol. 49, Iss. 4, 2010-04 ,pp. : 207-221

Adis International

Access to resources Recommend Favorite

The Influences of Aconitine, an Active/Toxic Alkaloid from Aconitum, on the Oral Pharmacokinetics of CYP3A Probe Drug Buspirone in Rats

By  

Drug Metabolism Letters, Vol. 8, Iss. 2, 2015-02 ,pp. : 135-144

Bentham Science Publishers

Access to resources Recommend Favorite

Effect of moxidectin on CYP3A4 activity as evaluated by oral midazolam pharmacokinetics in healthy subjects

By  

Clinical Pharmacology In Drug Development, Vol. 3, Iss. 2, 2014-03 ,pp. : 151-157

John Wiley & Sons Inc

Access to resources Recommend Favorite

Use of omeprazole sulfone in a single plasma sample as a probe for CYP3A4

By Böttiger Ylva  

European Journal of Clinical Pharmacology, Vol. 62, Iss. 8, 2006-08 ,pp. : 621-625

Springer Publishing Company

Access to resources Recommend Favorite